Business
-
Global Times: ‘China has become the center and focus of international attention’
BEIJING, Dec. 29, 2025
Lifestyle
Press Releases
-
Sperity Health Closes $2M Seed Round to Scale Physician-Led Proactive Care and Employer Risk Mitigation
Capital supports expansion of Medicine 3.0 platform as employers seek evidence-based prevention to reduce chronic
-
BaRupOn LLC Announces Major Power Generation Expansion at Liberty American Multi-sourced Power and Innovation Hub (LAMP)
BaRupOn LLC expands on-site power at LAMP in Liberty, Texas, reaching 60MW with Siemens turbines and planning
-
Eco Bidét—A Clean You Can Carry® is Revolutionizing On-the-Go Freshness for Portable Hygiene
Redefine cleanliness anywhere with a TSA-size approved hygiene mist that’s gentle on you and the planet. DENVER, CO,
-
Aspen Psychology Group Launches Seasonal Mental Health Awareness Campaign Ahead of the Holidays
Aspen Psychology Group launches a holiday mental health awareness campaign to support individuals and families facing
-
New High Blood Pressure Guidelines Spotlight Unique Risks for Women Across Reproductive and Menopausal Stages
DALLAS, TX, UNITED STATES, December 18, 2025 /EINPresswire.com/ — While new high blood pressure guidelines from the
-
HES Launches Bloom — A Spring-Inspired Employee Wellness Challenge to Reinvigorate Workplace Well-Being
Every detail in Bloom is designed to spark joy, movement, and camaraderie. It’s more than just a challenge — it’s a
-
Live Craft Championships Spotlight Skilled Trades Talent and Workforce Excellence in Southern California
ANAHEIM, CA, UNITED STATES, December 18, 2025 /EINPresswire.com/ — Associated Builders and Contractors Southern
-
Non-Opioid Therapeutics Market Insights, Shares and Growth Outlook 2025-2032: Rising Integration of Non-Opioid Options in Multimodal Pain Management Protocols – ResearchAndMarkets.com
The “Non-Opioid Therapeutics Market – Global Forecast 2025-2032” has been added to ResearchAndMarkets.com’s offering. This market research report focuses on the evolving landscape of the Non-Opioid Therapeutics Market. This sector…
-
Enveric Biosciences Announces Closing of Exercise of Warrants for $3.1 Million Gross Proceeds
Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced the closing of its previously…
-
U.S. FDA Approves NUZOLVENCE® (zoliflodacin), a First-in-Class, Single-dose, Oral Antibiotic for the Treatment of Uncomplicated Urogenital Gonorrhea in Adults and Adolescents
Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (NASDAQ: INVA), today announced that the U.S. Food and Drug Administration (FDA) has approved NUZOLVENCE® (zoliflodacin) for oral suspension, a first-in-class, single-dose…